Literature DB >> 28054346

Optimized logic rules reveal interferon-γ-induced modes regulated by histone deacetylases and protein tyrosine phosphatases.

Daniel Van Twisk1, Shawn P Murphy1,2, Juilee Thakar1,3.   

Abstract

The pro-inflammatory cytokine interferon-γ (IFN-γ) is critical for activating innate and adaptive immunity against tumours and intracellular pathogens. Interferon-γ is secreted at the fetal-maternal interface in pregnant women and mice. The outer layer of the placenta in contact with maternal blood is composed of semi-allogeneic trophoblast cells, which constitute the fetal component of the fetal-maternal interface. The simultaneous presence of pro-inflammatory IFN-γ and trophoblast cells at the fetal-maternal interface appears to represent an immunological paradox, for trophoblastic responses to IFN-γ could potentially lead to activation of maternal immunity and subsequent attack of the placenta. However, our previous studies demonstrate that IFN-γ responsive gene (IRG) expression is negatively regulated in human and mouse trophoblast cells. In human cytotrophoblast and trophoblast-derived choriocarcinoma cells, janus kinase signalling is blocked by protein tyrosine phosphatases (PTPs), whereas in mouse trophoblast, histone deacetylases (HDACs) inhibit IRG expression. Here, we used genome-wide transcriptional profiling to investigate the collective roles of PTPs and HDACs on regulation of IRG expression in human choriocarcinoma cells. Logic-rules were optimized to derive regulatory modes governing gene expression patterns observed upon different combinations of treatment with PTP and HDAC inhibitors. The results demonstrate that IRGs can be divided into several categories in human choriocarcinoma cells, each of which is subject to distinct mechanisms of repression. Hence, the regulatory modes identified in this study suggest that human trophoblast and choriocarcinoma cells may evade the potentially deleterious consequences of exposure to IFN-γ by using several overlapping mechanisms to block IRG expression.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  choriocarcinoma; interferon-γ signalling; logics; pervanadate; valproic acid

Mesh:

Substances:

Year:  2017        PMID: 28054346      PMCID: PMC5382347          DOI: 10.1111/imm.12707

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  35 in total

Review 1.  Signaling network model of chromatin.

Authors:  Stuart L Schreiber; Bradley E Bernstein
Journal:  Cell       Date:  2002-12-13       Impact factor: 41.582

Review 2.  Mechanisms of type-I- and type-II-interferon-mediated signalling.

Authors:  Leonidas C Platanias
Journal:  Nat Rev Immunol       Date:  2005-05       Impact factor: 53.106

Review 3.  Interferons, immunity and cancer immunoediting.

Authors:  Gavin P Dunn; Catherine M Koebel; Robert D Schreiber
Journal:  Nat Rev Immunol       Date:  2006-11       Impact factor: 53.106

4.  IL-10, TNF-α & IFN-γ: potential early biomarkers for preeclampsia.

Authors:  Ashok Kumar; Nargis Begum; Sudha Prasad; Sarita Agarwal; Shashi Sharma
Journal:  Cell Immunol       Date:  2013-07-02       Impact factor: 4.868

5.  A phosphorylation-acetylation switch regulates STAT1 signaling.

Authors:  Oliver H Krämer; Shirley K Knauer; Georg Greiner; Enrico Jandt; Sigrid Reichardt; Karl-Heinz Gührs; Roland H Stauber; Frank D Böhmer; Thorsten Heinzel
Journal:  Genes Dev       Date:  2009-01-15       Impact factor: 11.361

6.  Histone deacetylase activity is required to recruit RNA polymerase II to the promoters of selected interferon-stimulated early response genes.

Authors:  Shuji Sakamoto; Ramesh Potla; Andrew C Larner
Journal:  J Biol Chem       Date:  2004-06-11       Impact factor: 5.157

7.  In vivo treatment with interferon-gamma during early pregnancy in mice induces strong expression of major histocompatibility complex class I and II molecules in uterus and decidua but not in extra-embryonic tissues.

Authors:  R Mattsson; A Mattsson; R Holmdahl; A Scheynius; P H Van der Meide
Journal:  Biol Reprod       Date:  1992-06       Impact factor: 4.285

8.  Primary structure of the human follistatin precursor and its genomic organization.

Authors:  S Shimasaki; M Koga; F Esch; K Cooksey; M Mercado; A Koba; N Ueno; S Y Ying; N Ling; R Guillemin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

9.  Interferon-stimulated transcription and innate antiviral immunity require deacetylase activity and histone deacetylase 1.

Authors:  Inna Nusinzon; Curt M Horvath
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-25       Impact factor: 11.205

10.  TopHat: discovering splice junctions with RNA-Seq.

Authors:  Cole Trapnell; Lior Pachter; Steven L Salzberg
Journal:  Bioinformatics       Date:  2009-03-16       Impact factor: 6.937

View more
  7 in total

1.  Executable pathway analysis using ensemble discrete-state modeling for large-scale data.

Authors:  Rohith Palli; Mukta G Palshikar; Juilee Thakar
Journal:  PLoS Comput Biol       Date:  2019-09-03       Impact factor: 4.475

2.  Unbiased analysis of peripheral blood mononuclear cells reveals CD4 T cell response to RSV matrix protein.

Authors:  Juilee Thakar; Yu Qian; Lauren Benoodt; David Roumanes; Xing Qiu; Nathan Laniewski; ChinYi Chu; Christopher Slaunwhite; Lu Wang; Aishwarya Mandava; Ivan Chang; Ann R Falsey; Mary T Caserta; Thomas J Mariani; Richard H Scheuermann; Edward E Walsh; David J Topham
Journal:  Vaccine X       Date:  2020-04-21

3.  Molecular characterization of atherosclerosis in HIV positive persons.

Authors:  Adam Cornwell; Rohith Palli; Meera V Singh; Lauren Benoodt; Alicia Tyrell; Jun-Ichi Abe; Giovanni Schifitto; Sanjay B Maggirwar; Juilee Thakar
Journal:  Sci Rep       Date:  2021-02-05       Impact factor: 4.379

4.  A systems genomics approach uncovers molecular associates of RSV severity.

Authors:  Matthew N McCall; Chin-Yi Chu; Lu Wang; Lauren Benoodt; Juilee Thakar; Anthony Corbett; Jeanne Holden-Wiltse; Christopher Slaunwhite; Alex Grier; Steven R Gill; Ann R Falsey; David J Topham; Mary T Caserta; Edward E Walsh; Xing Qiu; Thomas J Mariani
Journal:  PLoS Comput Biol       Date:  2021-12-28       Impact factor: 4.779

5.  Executable models of immune signaling pathways in HIV-associated atherosclerosis.

Authors:  Mukta G Palshikar; Rohith Palli; Alicia Tyrell; Sanjay Maggirwar; Giovanni Schifitto; Meera V Singh; Juilee Thakar
Journal:  NPJ Syst Biol Appl       Date:  2022-09-21

6.  Innate immune signaling in trophoblast and decidua organoids defines differential antiviral defenses at the maternal-fetal interface.

Authors:  Liheng Yang; Eleanor C Semmes; Cristian Ovies; Christina Megli; Sallie Permar; Jennifer B Gilner; Carolyn B Coyne
Journal:  Elife       Date:  2022-08-17       Impact factor: 8.713

7.  Association of Dynamic Changes in the CD4 T-Cell Transcriptome With Disease Severity During Primary Respiratory Syncytial Virus Infection in Young Infants.

Authors:  Thomas J Mariani; Xing Qiu; ChinYi Chu; Lu Wang; Juilee Thakar; Jeanne Holden-Wiltse; Anthony Corbett; David J Topham; Ann R Falsey; Mary T Caserta; Edward E Walsh
Journal:  J Infect Dis       Date:  2017-11-15       Impact factor: 5.226

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.